日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Coccidioides immitis Probable cytosolic iron-sulfur protein assembly protein 1 (CIA1) CSB-YP627752DUV
CSB-EP627752DUV
CSB-BP627752DUV
CSB-MP627752DUV
CSB-EP627752DUV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coccidioides immitis Protein STU1 (STU1), partial CSB-YP627753DUV
CSB-EP627753DUV
CSB-BP627753DUV
CSB-MP627753DUV
CSB-EP627753DUV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coccidioides immitis 40S ribosomal protein S1 (RPS1) CSB-YP627754DUV
CSB-EP627754DUV
CSB-BP627754DUV
CSB-MP627754DUV
CSB-EP627754DUV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coccidioides immitis Putative DNA helicase INO80 (INO80), partial CSB-YP627755DUV
CSB-EP627755DUV
CSB-BP627755DUV
CSB-MP627755DUV
CSB-EP627755DUV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coccidioides immitis Protein transport protein SEC31 (SEC31), partial CSB-YP627756DUV
CSB-EP627756DUV
CSB-BP627756DUV
CSB-MP627756DUV
CSB-EP627756DUV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coccidioides immitis Exportin-T (LOS1), partial CSB-YP627757DUV
CSB-EP627757DUV
CSB-BP627757DUV
CSB-MP627757DUV
CSB-EP627757DUV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coccidioides immitis Mediator of RNA polymerase II transcription subunit 14 (RGR1), partial CSB-YP627758DUV
CSB-EP627758DUV
CSB-BP627758DUV
CSB-MP627758DUV
CSB-EP627758DUV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coccidioides immitis Metacaspase-1 (MCA1), partial CSB-YP627759DUV
CSB-EP627759DUV
CSB-BP627759DUV
CSB-MP627759DUV
CSB-EP627759DUV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coccidioides immitis Protein EFR3 (EFR3), partial CSB-YP627760DUV
CSB-EP627760DUV
CSB-BP627760DUV
CSB-MP627760DUV
CSB-EP627760DUV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coccidioides immitis ATP-dependent rRNA helicase RRP3 (RRP3) CSB-YP627761DUV
CSB-EP627761DUV
CSB-BP627761DUV
CSB-MP627761DUV
CSB-EP627761DUV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coccidioides immitis tRNA-dihydrouridine (47) synthase [NAD (P) (+)] (DUS3), partial CSB-YP627762DUV
CSB-EP627762DUV
CSB-BP627762DUV
CSB-MP627762DUV
CSB-EP627762DUV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coccidioides immitis Endochitinase 1 (CTS1) CSB-BP627763DUV
CSB-MP627763DUV
CSB-EP627763DUV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coccidioides immitis Eukaryotic translation initiation factor 3 subunit D (CIMG_02370), partial CSB-YP627764DUV
CSB-EP627764DUV
CSB-BP627764DUV
CSB-MP627764DUV
CSB-EP627764DUV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coccidioides immitis ATP-dependent RNA helicase CHL1 (CHL1), partial CSB-YP627765DUV
CSB-EP627765DUV
CSB-BP627765DUV
CSB-MP627765DUV
CSB-EP627765DUV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coccidioides immitis Autophagy-related protein 2 (ATG2), partial CSB-YP627766DUV
CSB-EP627766DUV
CSB-BP627766DUV
CSB-MP627766DUV
CSB-EP627766DUV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coccidioides immitis Ubiquitin-like protein ATG12 (ATG12) CSB-YP627767DUV
CSB-EP627767DUV
CSB-BP627767DUV
CSB-MP627767DUV
CSB-EP627767DUV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coccidioides immitis Sensitive to high expression protein 9 homolog, mitochondrial (SHE9), partial CSB-YP627768DUV
CSB-EP627768DUV
CSB-BP627768DUV
CSB-MP627768DUV
CSB-EP627768DUV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coccidioides immitis Endochitinase 2 (CTS2), partial CSB-YP627769DUV
CSB-EP627769DUV
CSB-BP627769DUV
CSB-MP627769DUV
CSB-EP627769DUV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coccidioides immitis Nucleolar protein 16 (NOP16) CSB-YP627770DUV
CSB-EP627770DUV
CSB-BP627770DUV
CSB-MP627770DUV
CSB-EP627770DUV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Ethylene-responsive transcription factor ERF023 (ERF023) CSB-YP627771DOA
CSB-EP627771DOA
CSB-BP627771DOA
CSB-MP627771DOA
CSB-EP627771DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×